Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Keyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 8
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Biomimetic exosome harnessing exosomal lipidomics and functional proteins for PEDF-pDNA delivery in high altitude pulmonary edema intervention
Huiyang Li, Jinming Liu, Luqiao Wang, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 652-677
Closed Access
Revolutionizing Nanovaccines: A New Era of Immunization
Mohammed A. Saleh, Ahmed El-Moghazy, Adel Helmy Elgohary, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 126-126
Open Access
Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods
Andrew Webb, Emma N. Welbourne, Caroline A. Evans, et al.
Journal of Chromatography A (2025), pp. 465724-465724
Closed Access
The Past, Present, and Future of Cervical Cancer Vaccines
Alexander C. Lien, Gertrude C. Johnson, Tianyun Guan, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 201-201
Open Access
Adopting tomorrow’s therapies today: a perspective review of adoptive cell therapy in lung cancer
Faith Abodunrin, Daniel J. Olson, Oluwatosin Emehinola, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Recent Advances and Prospects in RNA Drug Development
Hidenori Tani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12284-12284
Open Access | Times Cited: 4
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 2
Advances in Engineering Circular RNA Vaccines
Zhongyan Zhang, Yuanlei Fu, Xiaoli Ju, et al.
Pathogens (2024) Vol. 13, Iss. 8, pp. 692-692
Open Access | Times Cited: 2
Nanomedicine for cancer patient‐centered care
Carlo Sorrentino, Stefania L. Ciummo, Cristiano Fieni, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Nasal mRNA Nanovaccine with Key Activators of Dendritic and MAIT Cells for Effective Against Lung Tumor Metastasis in Mice Model
Ang Li, Xushan Cai, Dong Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 11479-11497
Open Access | Times Cited: 1
Next generation of mRNA and lncRNAs based-vaccines platforms: Highlighted for HPV in head and neck squamous cell carcinoma, cervical and colorectal cancers and oncogenic viruses HBV/HCV in hepatocellular carcinoma
RACHEL SIQUEIRA DE QUEIROZ SIMÕES
International Journal of Biological and Pharmaceutical Sciences Archive (2024) Vol. 7, Iss. 1, pp. 095-100
Open Access
mRNA vaccines in cancer clinical trials: HPV16 tumor-derived antigens (e6 and e7 oncoproteins) associated with head and neck squamous cell carcinoma (HNSCC), oropharyngeal and cervical cancers
Rita Simões
Open Access Research Journal of Life Sciences (2024) Vol. 7, Iss. 1, pp. 046-051
Open Access
An MST-based assay reveals new binding preferences of IFIT1 for canonically and non-canonically capped RNAs
Tomasz Śpiewla, Katarzyna Grab, Anaïs Depaix, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Advances and challenges in anti-cancer vaccines for multiple myeloma
Pegah Abdollahi, Hanne Marie Norseth, Fredrik Schjesvold
Frontiers in Immunology (2024) Vol. 15
Open Access
Peptide Vaccines in Cancer Immunotherapy
Neeraj Kumar Chouhan, Mamta N. Talati, Mani Sharma, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 235-264
Closed Access
mRNA Fragmentation Pattern Detected by SHAPE
Shanshan Feng, Ting Chen, Yunlong Zhang, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 10249-10258
Open Access
Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu
Flavia Ferrantelli, Francesco Manfredi, Micaela Donnini, et al.
Cancer Gene Therapy (2024)
Open Access
Page 1 - Next Page

Scroll to top